| Literature DB >> 34805561 |
Ibraín Enrique Corrales-Reyes1, Frank Hernández-García2, Adrián Alejandro Vitón-Castillo3, Christian R Mejia4.
Abstract
INTRODUCTION: COVID-19 is a disease with worldwide impact that has fully caught attention of researchers. The Cuban scientific output, after one year of confronting this pandemic, has not been studied from a bibliometric perspective.Entities:
Keywords: Bibliometrics; COVID-19; Cuba; SARS-CoV-2; Scientometrics
Year: 2021 PMID: 34805561 PMCID: PMC8586785 DOI: 10.1016/j.heliyon.2021.e08258
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Search strategy.
| Operator | Field | Search term |
|---|---|---|
| TITLE-ABS-KEY | 2019 ncov, 2019 novel coronavirus, 2019 novel coronavirus (2019-ncov), 2019 novel coronavirus disease, 2019 novel coronavirus pneumonia, 2019-nCoV, 2019-novel CoV, coronavirus 2019, coronavirus disease 2019, cov-19, covid, COVID-19, COVID-19 vaccines, COVID-19 testing, COVID-19 serological testing, COVID-19 nucleic acid testing, covid-19 diagnosis, covid-19 pandemic, covid-19 pneumonia, COVID-19 virus infection, covid-2019 epidemic, ncov-2019, new coronavirus, novel coronavirus, novel coronavirus outbreak, novel coronavirus pneumonia, SARS-CoV-2, sars-cov-2 infection, severe acute respiratory syndrome coronavirus 2, Wuhan coronavirus | |
| AND | SRCTYPE | j |
| AND | AFFILCOUNTRY | Cuba |
| AND | LIMIT-TO | DOCTYPE, "ar" OR DOCTYPE, "re" |
General indicators of the Cuban scientific output in Scopus after one year of confronting the COVID-19 in the country.
| Indicator | Value |
|---|---|
| Ndoc | 133 |
| NCit | 111 |
| Cited doc (%) | 39 (29.3) |
| Cpd | 0.8 |
| h index | 5 |
| Ndoc Sp (%) | 93 (69.9) |
| Ndoc Eng (%) | 39 (29.3) |
| Ndoc Sp & Eng (%) | 1 (0.8) |
| Lead (%) | 112 (84.2) |
| NC (%) | 55 (41.4) |
| IC (%) | 28 (21.1) |
| IC Lead (%) | 8 (6.0) |
| IC & NC (%) | 5 (3.8) |
| NoCollab (%) | 45 (33.8) |
Indicators by quartiles after one year of confronting the COVID-19 in Cuba.
| Indicators | Q1 | Q2 | Q3 | Q4 | Non-ranked |
|---|---|---|---|---|---|
| Ndoc (%) | 18 (13.5) | 8 (6.0) | 37 (27.8) | 60 (45.1) | 10 (7.5) |
| NCit | 21 | 23 | 20 | 44 | 3 |
| Cpd | 1.2 | 2.9 | 0.5 | 0.7 | 0.3 |
| Cited doc (%) | 9 (50.0) | 3 (37.5) | 9 (24.3) | 16 (26.7) | 2 (20.0) |
| Ndoc Sp (%) | - | - | 29 (78.4) | 57 (95.0) | 7 (70.0) |
| Ndoc Eng (%) | 18 (100) | 8 (100) | 7 (18.9) | 3 (5.0) | 3 (30.0) |
| Ndoc Sp & Eng (%) | - | - | 1 (2.7) | - | - |
| Lead (%) | 7 (38.9) | 6 (75.0) | 33 (89.2) | 58 (96.7) | 8 (80.0) |
| NC (%) | 5 (27.8) | 4 (50.0) | 12 (32.4) | 33 (55.0) | 1 (10.0) |
| IC (%) | 10 (55.6) | 3 (37.5) | 7 (18.9) | 4 (6.7) | 4 (40.0) |
| IC & NC (%) | 2 (11.1) | - | - | 2 (3.3) | 1 (10.0) |
| NoCollab (%) | 1 (5.6) | 1 (12.5) | 18 (48.6) | 21 (35.0) | 4 (40.0) |
Indicators of output, visibility, leadership, impact and collaboration in the most productive institutions (≥7 articles).
| Indicator | Medical University of Havana | Pedro Kourí Institute of Tropical Medicine | Luis Díaz Soto Central Military Hospital | National Institute of Cardiology and Cardiovascular surgery | Center of Molecular Immunology | University of Havana | Hermanos Ameijeiras Clinical-Surgical Hospital | National Institute of Neurology and Neurosurgery | National Institute of Hematology and Immunology |
|---|---|---|---|---|---|---|---|---|---|
| Ndoc (%) | 37 (27.8) | 17 (12.8) | 9 (6.8) | 9 (6.8) | 8 (6.0) | 7 (5.3) | 7 (5.3) | 7 (5.3) | 7 (5.3) |
| NCit | 40 | 22 | 3 | 6 | 4 | 5 | 4 | 2 | - |
| Cpd | 1.1 | 1.3 | 0.3 | 0.7 | 0.5 | 0.7 | 0.6 | 0.3 | - |
| Cited doc (%) | 16 (43.2) | 9 (52.9) | 1 (11.1) | 3 (33.3) | 3 (37.5) | 2 (28.6) | 2 (28.6) | 1 (14.3) | - |
| Ndoc Sp (%) | 30 (81.1) | 6 (35.3) | 5 (55.6) | 4 (44.4) | 1 (12.5) | 3 (42.9) | 5 (71.4) | 3 (42.9) | 6 (100) |
| Ndoc Eng (%) | 7 (18.9) | 11 (64.7) | 4 (44.4) | 4 (44.4) | 7 (87.5) | 4 (57.1) | 2 (28.6) | 4 (57.1) | 1 (14.3) |
| Ndoc Sp & Eng (%) | - | - | - | 1 (11.1) | - | - | - | - | - |
| Lead (%) | 34 (91.9) | 13 (76.5) | 9 (100) | 4 (44.4) | 7 (87.5) | 4 (57.1) | 6 (85.7) | 5 (71.4) | 6 (100) |
| NC (%) | 24 (64.9) | 8 (47.1) | 4 (44.4) | 2 (22.2) | 6 (75.0) | 3 (42.9) | 3 (42.9) | 3 (42.9) | 3 (42.9) |
| IC (%) | 2 (5.4) | 4 (23.5) | - | 5 (55.6) | 1 (12.5) | 3 (42.9) | 1 (14.3) | 4 (57.1) | - |
| IC Lead (%) | - | 1 (5.9) | - | - | - | - | - | 2 (28.6) | - |
| IC & NC (%) | 2 (5.4) | 2 (11.8) | 1 (11.1) | - | 1 (12.5) | 1 (14.3) | 1 (14.3) | - | - |
| NoCollab (%) | 9 (24.3) | 3 (17.6) | 4 (44.4) | 2 (22.2) | - | - | 2 (28.6) | - | 4 (57.1) |
| Q1 (%) | 2 (5.4) | 6 (35.3) | - | 1 (11.1) | 4 (50.0) | 3 (42.9) | 2 (28.6) | 1 (14.3) | - |
| Q1 Lead (%) | - | 3 (17.6) | - | - | 3 (37.5) | - | 2 (28.6) | - | - |
| Q2 (%) | 3 (8.1) | 3 (17.6) | 2 (22.2) | 2 (22.2) | 2 (25.0) | - | - | - | - |
| Q3 (%) | 12 (32.4) | 4 (23.5) | 5 (55.6) | 2 (22.2) | 1 (12.5) | 1 (14.3) | - | 3 (42.9) | - |
| Q4 (%) | 20 (54.1) | 3 (17.6) | 1 (11.1) | 1 (11.1) | - | 2 (28.6) | 3 (42.9) | 2 (28.6) | 7 (100) |
| Non-ranked (%) | - | 1 (5.9) | 1 (11.1) | 3 (33.3) | 1 (12.5) | 1 (14.3) | 2 (28.6) | 1 (14.3) | - |
Indicators of output, impact, leadership and collaboration in journals with five or more articles on COVID-19 after one year of confronting the COVID-19 in the country.
| Journal (Quartile) | Ndoc | NCit | Cpd | Cited doc (%) | Lead (%) | NoCollab (%) | NC (%) | IC (%) | NC & IC (%) |
|---|---|---|---|---|---|---|---|---|---|
| Revista Habanera de Ciencias Médicas (Q4) | 26 | 41 | 1.6 | 13 (50.0) | 26 (100) | 8 (30.8) | 17 (65.4) | 1 (3.8) | - |
| Revista Cubana de Pediatría (Q4) | 15 | 1 | 0.1 | 1 (6.7) | 14 (93.3) | 5 (33.3) | 8 (53.3) | 1 (6.7) | 1 (6.7) |
| Revista Cubana de Medicina Militar (Q3) | 11 | - | - | - | 10 (90.9) | 9 (81.8) | 1 (9.1) | 1 (9.1) | - |
| Revista Cubana de Hematología, Inmunología y Hemoterapia (Q4) | 8 | - | - | - | 8 (100) | 4 (50.0) | 4 (50.0) | - | - |
| Revista Cubana de Investigaciones Biomédicas (Q3) | 8 | 7 | 0.9 | 3 (37.5) | 8 (100) | 3 (37.5) | 5 (62.5) | - | - |
| Revista Cubana de Cardiología y Cirugía Cardiovascular (non-ranked) | 5 | 1 | 0.2 | 1 (20.0) | 5 (100) | 3 (60.0) | 1 (20.0) | 1 (20.0) | - |
| Educación Médica Superior (Q3) | 5 | - | - | - | 5 (100) | 3 (60.0) | 2 (40.0) | - | - |
Figure 1Scientific collaboration networks among countries with articles published with Cuban researchers.